Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 272.50 GBp
Change Today -32.50 / -10.66%
Volume 41.7K
IDH On Other Exchanges
As of 11:35 AM 05/29/15 All times are local (Market data is delayed by at least 15 minutes).

immunodiagnostic systems hld (IDH) Snapshot

275.00 GBp
Previous Close
305.00 GBp
Day High
289.00 GBp
Day Low
267.50 GBp
52 Week High
06/24/14 - 537.50 GBp
52 Week Low
05/29/15 - 267.50 GBp
Market Cap
Average Volume 10 Days
0.19 GBp
Shares Outstanding
9.44 GBp
Dividend Yield

Related News

No related news articles were found.

immunodiagnostic systems hld (IDH) Related Businessweek News

No Related Businessweek News Found

immunodiagnostic systems hld (IDH) Details

Immunodiagnostic Systems Holdings PLC, together with its subsidiaries, develops and supplies immunoassay kits and automated immunoanalyser technologies for use in research, medical, and pharmaceutical applications worldwide. The company offers immunodiagnostic kits for use in the investigation of bone, cartilage, growth, and hypertension areas, as well as calcium metabolism and chronic kidney disease; and distributes a range of antibodies, enzymes, and peptides for various specialty areas, including oncology, inflammation, neuroscience, and fertility. It also provides IDS-iSYS, an automated immunoassay system. The company was incorporated in 2004 and is headquartered in Boldon, the United Kingdom.

328 Employees
Last Reported Date: 06/23/14
Founded in 2004

immunodiagnostic systems hld (IDH) Top Compensated Officers

Chief Financial Officer, Group Finance Direct...
Total Annual Compensation: 223.0K GBP
Executive Officer of North American Operation...
Total Annual Compensation: --
Compensation as of Fiscal Year 2014.

immunodiagnostic systems hld (IDH) Key Developments

Immunodiagnostic Systems Holdings plc Provides Revenue Guidance for the Year Ended March 31, 2015 and March 31, 2016

Immunodiagnostic Systems Holdings plc provides revenue guidance for the year ended March 31, 2015 and March 31, 2016. For the year ended March 31, 2015 revenues are expected to be £45 million in line with the guidance reconfirmed in April 2015. The board expects that for the current financial year to 31 March 2016 revenues will be in the range of £39-£42 million.

Immunodiagnostic Systems Holdings plc Provides Revenue Guidance for the Year Ended March 31, 2015

Immunodiagnostic Systems Holdings plc provided revenue guidance for the year ended March 31, 2015. Total revenues are expected to be £45 million (2014: £52 million) in line with guidance given in September 2014. The decrease in revenue was driven by lower automated revenues, due to a low level of net placements, and continued significant decline in manual revenues, predominantly in 25OH vitamin D.

Immunodiagnostic Systems Holdings plc Announces Management Changes

Immunodiagnostic Systems Holdings plc announced that Patricio Lacalle has officially taken up his position as Chief Executive Officer. In addition, Burkhard Wittek, Executive Chairman, will revert to being Non-Executive Chairman with immediate effect.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IDH:LN 272.50 GBp -32.50

IDH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for IDH.
View Industry Companies

Industry Analysis


Industry Average

Valuation IDH Industry Range
Price/Earnings 15.2x
Price/Sales 1.8x
Price/Book 1.0x
Price/Cash Flow 15.1x
TEV/Sales 1.8x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMMUNODIAGNOSTIC SYSTEMS HLD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at